CCL17 and neoplasm: Alternatively, transducing chemokine receptors specific for tumour-produced chemokines in anti-tumour lymphocytes have improved homing and antitumor response in vivo; for example T cells equipped with chimeric receptors such as CCR4, the receptor for CCL17, resulted in a strong response against Hodgkin’s tumour models [112].